Hall, Michael J. and Olopade, Olufunmilayo I.
The impact of predictive genetic testing on cancer care can be measured by the increased demand for and utilization of genetic services as well as in the progress made in reducing cancer risks in known mutation carriers. Nonetheless, differential access to and utilization of genetic counseling and cancer predisposition testing among underserved racial and ethnic minorities compared with the white population has led to growing health care disparities in clinical cancer genetics that are only beginning to be addressed. Furthermore, deficiencies in the utility of genetic testing in underserved populations as a result of limited testing experience and in the effectiveness of risk reducing interventions compound access and knowledge-base disparities. The recent literature on racial/ethnic health care disparities is briefly reviewed, and is followed by a discussion of the current limitations of risk assessment and genetic testing outside of white populations. The importance of expanded testing in underserved populations is emphasized.
|Export/Citation:||EndNote | BibTeX | Dublin Core | ASCII (Chicago style) | HTML Citation | OpenURL | Reference Manager|
|Social Networking:|| |
|Additional Information:||Access to full text is subject to the publisher's access restrictions.|
|Uncontrolled Keywords:||predictive genetic testing, cancer care, reducing cancer risks, genetic counseling, cancer predisposition testing, racial/ethnic health care disparities|
|Subjects:||Health > Health Equity|
Health > Disparities
Health > Public Health > Chronic Illness & Diseases
Health > Public Health > Chronic Illness & Diseases > Cancer
Research > Genetics and Race
|Depositing User:||Users 141 not found.|
|Date Deposited:||02 Apr 2011|
|Last Modified:||25 May 2011 10:02|
|Link to this item (URI):||http://health-equity.lib.umd.edu/id/eprint/650|
Actions (login required)